Eubiologics. Co. Ltd. announced that it has received $7.5 million in funding led by new investor, Global Health Investment Fund I, LLC, a fund managed by Lion's Head Global Partners, Investment Arm on August 27, 2014.

The company issued preferred shares and senior secured loan in the transaction. Global Health Investment Fund I, Llc invested $5 million in the transaction. The transaction also included participation from returning investors, Korea Investment Global Frontier Fund No.

20, a fund managed by Korea Investment Partners Co. Ltd. and Korea Seoul Life Science Fund, a fund co-managed by Oxford Bioscience Partners and Hanwha Investment Corp.